Head and Neck Cancer News & Features
Patients with allergic rhinitis may have an increased risk of developing nasopharyngeal carcinoma.
A majority of patients enrolled in a phase 1 trial of CUDC-101 were found to be free progression at 1.5 years of median follow-up, according to a published report.
Investigators have uncovered genomic differences, with potentially important clinical implications, in head and neck cancers caused by infection with the human papillomavirus.
Significant benefits of exercise regimen in reducing the effect of percutaneous endoscopic gastrostomy placement on swallowing function for patients with head and neck cancer.
The addition of head and neck cancer screenings to regular lung cancer screenings could improve early detection and survival, according to published research.
Head and Neck Cancer Clinical Trials
- New treatment method shrinks ovarian cancer tumors and improves chemotherapy effectiveness
- Epigenetic signatures differentiate triple negative breast cancers
- Novel drug approved for multiple myeloma
- Radiation therapy used most often for prostate cancer regardless of decision-making factors
- Women educated on overdiagnsosis are less likely to want mammogram
- Farydak (panobinostat) now FDA-approved for multiple myeloma
- ASCO: Testicular cancer history may indicate greater risk of developing prostate cancer
- Urine test could help to guide treatment of bladder cancer
- Multiple studies are exploring whether e-cigarettes help smokers quit or continue smoking
- Study identifies reasons for ibrutinib discontinuation in patients with chronic lymphocytic leukemia
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|